Proactive Investors - Run By Investors For Investors

Cosmos Holdings acquires Cosmofarm in Greece

Cosmofarm, a pharmaceutical wholesaler, reported sales of about $14 million in fiscal 2017
Cosmofarm logo
Athens-based Cosmofarm is in the process of relocating to a new 32,000 square foot facility

Cosmos Holdings Inc (OTCQB:COSM) has closed its acquisition of Cosmofarm Ltd, a privately held pharmaceutical company based in Greece.

Established in 1994, Cosmofarm is a pharmaceutical wholesale company in Athens, which provides a comprehensive range of pharmaceutical products. Its core business focuses on sourcing and distributing branded and generic medicines, over-the-counter pharmaceuticals, food supplements and medical devices to more than 1,130 pharmacies.

READ: Cosmos posts 3Q profit and strong profit margins on booming drug sales and bolstered balance sheet

Cosmofarm conducts business with as many as 250 pharmaceutical manufacturers and wholesalers and reported sales of about $14 million for the 2017 fiscal year.

The financial details of the Cosmofarm acquisition haven’t been disclosed.

Cosmos Holdings CEO Gregory Siokas is bullish about the takeover and so are investors who sent Cosmos shares up by 9.4% to $3.50 in Friday’s morning trading session.

READ: Cosmos Holdings focuses on Europe as it expands its global wholesale pharmaceutical business

“We are excited to announce the closing of this acquisition and to have Cosmofarm’s talented team become part of Cosmos Holdings,” Siokas said. “Cosmofarm will play a key role in increasing sales of our SkyPremium Life product line to pharmacies."

Cosmofarm is in the process of relocating to a new 32,000 square foot facility that features a robotic fulfillment center and offers 20 times the capacity of its old warehouse, according to Siokas.

Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and in Harlow, UK.  The Chicago-based company conducts business in Germany, the United Kingdom, Ireland, the United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Jordan, Sweden, Poland, the Netherlands, and Greece. 

 

Contact Ellen Kelleher at [email protected] 

View full COSM profile View Profile

Cosmos Holdings Inc Timeline

Related Articles

Scientist at work
May 28 2019
CaPre, a potent form of Omega-3, has been shown to reduce triglycerides, but also lower 'bad cholesterol' levels, and raise 'good' ones
Dyadic Dyadic International founder and CEO Mark Emalfarb
June 04 2019
The biotechnology platform company helps drug makers negotiate the cost curve from discovery to large-scale manufacturing of low-cost enzymes and proteins that can ultimately lower the cost of healthcare
cancerous cells
March 08 2019
A series of trials underway at major cancer research hospitals are evaluating the company's flagship cancer drug Ampligen
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use